Intraventricular B7-H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: Preliminary First-in-Human Bioactivity and SafetyNicholas A. Vitanza, Julie R. Park, Amy Lee et al.|Cancer Discovery|2022Cited by 277
Planned Interim Analysis of a Phase 2 Investigator-Initiated Trial of Anakinra to Prevent CRS and Neurotoxicity after Treatment with Lisocabtagene MaraleucelEmily C. Liang, Jordan Gauthier, Aya Albittar et al.|Transplantation and Cellular Therapy|2024Cited by 2
Phase 2 Study of Anakinra to Prevent CRS and Neurotoxicity after Treatment with Lisocabtagene Maraleucel: Planned Interim AnalysisJordan Gauthier, Aya Albittar, Andrew J. Portuguese et al.|Blood|2023Cited by 2
Supplementary Data from Intraventricular B7-H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: Preliminary First-in-Human Bioactivity and SafetyNicholas A. Vitanza, Julie R. Park, Ashley Wilson et al.|Unknown|2023Cited by 0
Supplementary Data from Intraventricular B7-H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: Preliminary First-in-Human Bioactivity and SafetyNicholas A. Vitanza, Julie R. Park, Ashley Wilson et al.|Unknown|2023Cited by 0